The eyesON R&D Efficiency: Big Pharma Overview visualizer presents a clear, data-focused view of how R&D spending translates into regulatory outcomes across major publicly traded pharmaceutical companies.
By connecting R&D investment levels with FDA-approved New Molecular Entities (NMEs) and Biologic License Applications (BLAs), the tool illustrates how efficiently organizations convert research spending into approved innovation. The result is a comparative view of R&D Return on Investment (ROI) across the industry.
Rather than relying on static tables or isolated metrics, the visualizer allows users to explore the relationship between strategic investment and regulatory success in a single interactive environment.
The visualizer supports analysis of pharmaceutical innovation performance at a company level.
R&D Spend vs. Regulatory Output
Company-Level Innovation Profiles
ROI-Oriented Insights
The eyesON R&D Efficiency visualizer is built to reveal patterns behind innovation performance. By presenting data visually, it helps users move beyond raw figures and see how investment strategies align with regulatory achievements across the industry.
It is equally relevant for professionals refining R&D decision-making and for anyone interested in understanding how large pharmaceutical organizations translate research budgets into approved therapies.
Where Do the Data and Methods Come From?
The visualizer uses publicly available financial data from sec.gov and gurufocus.com, combined with FDA approval data for NMEs and BLAs from fda.gov. More details on data sources, extraction methods, and the analytical approach are available in the Data Definition tab within the app.
R&D Efficiency: Big Pharma Overview is part of eyesON, a series of free interactive data visualizers developed by Cyntegrity. The eyesON series reflects Cyntegrity’s commitment to sharing data analytics capabilities and clinical research expertise with the wider research community. Each visualizer is designed to make complex industry data easier to explore, compare, and apply in real-world decision-making.
Interested in exploring more interactive data visualizers from Cyntegrity? You can discover the full eyesON collection through the platform. Explore More Interactive Visualizers…
See how other datasets can sharpen signal awareness and decision-making.
Need a quote, speaker, or more info about Cyntegrity? Reach out directly to our media contact for timely assistance.
Featured Insights
Start Your Roll-Out
RBQM Capability Pathway
Quick Answers
Presented By
Dr. Artem Andrianov
Cyntegrity
Presented By
Shehnaz Vakharia
ADAMAS Consulting
From retrospective QA → to continuous, data-driven oversight
Date
April, 27th 2026
